Skip to the rundown
GetYourBrief Topic · GLP-1 Receptor Agonists
Search

Topic · in the news since February 19, 2026

GLP-1 Receptor Agonists news

GLP-1 Receptor Agonists appeared in 5 news events on GetYourBrief between February 19, 2026 and September 24, 2026, on the Healthcare, Biotech and Legal desks. The latest: "GLP-1 drugmakers face lawsuits over alleged sudden vision loss risk" (September 22, 2026).

When was GLP-1 Receptor Agonists in the news?

News events naming GLP-1 Receptor Agonists per month (one per story, however many outlets carried it). Source: GetYourBrief's record of the outlets' reports. April 2026 and May 2026: the intake of reports was interrupted, so these months undercount.

The latest news about GLP-1 Receptor Agonists

  1. Sep 22 · Biotech GLP-1 drugmakers face lawsuits over alleged sudden vision loss risk 4
  2. Sep 9 · Biotech Study links semaglutide to fewer asthma attacks, COPD flare-ups 2
  3. Jul 21 · Legal Novo Nordisk sues Eli Lilly over alleged false advertising 5
  4. Mar 10 · Healthcare GLP-1 receptor agonists are being investigated as a treatment for addiction. 4

Which desks cover GLP-1 Receptor Agonists?

  1. Healthcare 2
  2. Biotech 2
  3. Legal 1

Who appears in the news with GLP-1 Receptor Agonists?

  1. Novo Nordisk 5
  2. Eli Lilly 4
  3. Food and Drug Administration 2
  4. Wegovy 2
  5. Semaglutide 2
  6. Ozempic 2

Sources: the outlets' reports linked on this page; counts and times from GetYourBrief's record of those reports (methodology).